EXICURE, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2430 N. HALSTED ST., CHICAGO, IL, 60614
Mailing Address 2430 N. HALSTED ST., CHICAGO, IL, 60614
Phone 847-673-1707
Fiscal Year End 1231
EIN 815333008
Financial Overview
FY2024
$14.92M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 10, 2026 | View on SEC |
| 8-K Current report of material events | January 22, 2026 | View on SEC |
| 4 Insider stock transaction report | January 21, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 21, 2026 | View on SEC |
| 4 Insider stock transaction report | January 20, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 20, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | December 10, 2025 | View on SEC |
| 4 Insider stock transaction report | December 10, 2025 | View on SEC |
Material Events
8-K Leadership Change February 10, 2026
High Impact
- New board members Jung Kyu Ham, Jung Soo Kim, and Gyeung Seog Cheon appointed to provide fresh perspectives and oversight.
- Company stated resignations did not stem from disagreements, suggesting a planned transition.
Insider Trading
STRONG SELL 2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.